CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Planned sale Chief Financial Officer sold 1,597 shares at $28.36 ($45,291)
- 4 Planned sale Chief Commercial Officer sold 1,618 shares at $28.36 ($45,886)
- 4 Option exercise Director acquired 4,975 shares (option exercise)
- 4 Option exercise Director acquired 4,975 shares (option exercise)
- 4 Option exercise Director acquired 4,975 shares (option exercise)
- 4 Option exercise Director acquired 4,975 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Shareholder vote results
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
Page 16 of 66 · 1,304 filings